This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- NM-004
- DrugBank Accession Number
- DB18066
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
Structure for NM-004 (DB18066)
- Weight
- Average: 300.27
Monoisotopic: 300.074621494 - Chemical Formula
- C15H12N2O5
- Synonyms
- 5-((e)-(4-(carboxymethyl)phenyl)azo)-2-hydroxy-benzoic acid
- 5-(4-carboxymethyl-phenylazo)-2-hydroxy-benzoic acid
- Benzeneacetic acid, 4-(2-(3-carboxy-4-hydroxyphenyl)diazenyl)-
- External IDs
- INN-108
- NAA-004
- NM-004
- NOBEX-AA-004
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Product Ingredients
Ingredient UNII CAS InChI Key NM-004 disodium QS757J8N0F Not Available TXJBXFLHWJRGQI-WXIBIURSSA-L
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- QIU74LKJ78
- CAS number
- 402934-69-4
- InChI Key
- FNRNBCNUWGWVFO-WUKNDPDISA-N
- InChI
- InChI=1S/C15H12N2O5/c18-13-6-5-11(8-12(13)15(21)22)17-16-10-3-1-9(2-4-10)7-14(19)20/h1-6,8,18H,7H2,(H,19,20)(H,21,22)/b17-16+
- IUPAC Name
- 5-[(1E)-2-[4-(carboxymethyl)phenyl]diazen-1-yl]-2-hydroxybenzoic acid
- SMILES
- OC(=O)CC1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O
References
- General References
- Not Available
- External Links
- ChemSpider
- 10683927
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 4.02 Chemaxon pKa (Strongest Acidic) 2.97 Chemaxon pKa (Strongest Basic) 0.17 Chemaxon Physiological Charge -2 Chemaxon Hydrogen Acceptor Count 7 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 119.55 Å2 Chemaxon Rotatable Bond Count 5 Chemaxon Refractivity 80.92 m3·mol-1 Chemaxon Polarizability 29.7 Å3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at September 08, 2023 21:03 / Updated at April 30, 2024 13:34